General Updates

17th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub: Dissolution of Wholly Owned Subsidiary (WOS) Ref: Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we would like to inform you that the Curatio Inc., Philippines Wholly Owned Subsidiary (WOS) of the Company domiciled in Philippines, has been voluntarily dissolved with effect from 10-Jul-26. The Company has received communication of above dissolution on 17-Jul-26 from Philippines. The details as required under Regulation 30 of Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30-Jan-26 is enclosed herewith as Annexure. You are requested to take the above on records. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com Annexure Sr Particulars Details 1 The amount and percentage of the turnover or revenue or Details as on 31-Mar-26 income and net worth contributed by such unit or division or undertaking or subsidiary or associate company of the Turnover for FY 2025-26: listed entity during the last financial year; Nil (0%) Net worth for FY 2025-26: Rs 1.3 Crores (0.02%) 2 Date on which the agreement for sale has been entered Not applicable as entity has into; dissolved by shortening of term of existence via amendment in Articles of Incorporation 3 The expected date of completion of sale/disposal; Not Applicable 4 Consideration received from such sale/disposal; Not Applicable as entity has been dissolved 5 Brief details of buyers and whether any of the buyers Not Applicable belong to the promoter/ promoter group/group companies. If yes, details thereof; 6 Whether the transaction would fall within related party Not Applicable transactions? If yes, whether the same is done at “arm’s length”; 7 Whether the sale, lease or disposal of the undertaking is Not Applicable outside Scheme of Arrangement? If yes, details of the same including compliance with regulation 37A of LODR Regulations. Email – investorservices@torrentpharma.com 8 Additionally, in case of a slump sale, indicative Not Applicable disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale. Email – investorservices@torrentpharma.com